PCSK9 and atherosclerosis: Similarly, fisetin reduced the buildup of lipids in the plaque that causes atherosclerosis by decreasing the activity of proprotein convertase subtilisin/kexin type 9 (PCSK9) and lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1).